Mirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trial Medical Dialogues Bureau2 Nov 2019 9:00 AM ISTOut of 17 patients enrolled in the Phase 1 trial of Mirati Therapeutics' oral drug MRTX849, 12 have been evaluated, including six with lung cancer and...
GSK: US pharma president Jack Bailey to step down in December Medical Dialogues Bureau22 Aug 2019 9:15 AM ISTCommenting on his time at GSK, Jack Bailey said, "After more than a decade at GSK and nearly three decades in the life sciences industry, I look...
Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report Medical Dialogues Bureau15 July 2019 9:30 AM ISTThe deal is the largest Gilead has executed since new Chief Executive Officer Dan O'Day took the reins in March as he attempts to bolster the San...
Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm Medical Dialogues Bureau10 July 2019 10:04 AM ISTThe Mucinex D brand and store brands had combined US sales of approximately USD 71 million MAT (moving annual turnover) for the most recent 12 months...
Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy Medical Dialogues Bureau8 July 2019 1:32 PM ISTAs part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene Medical Dialogues Bureau26 Jun 2019 9:00 AM ISTBristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
Global forum to examine use of safer nicotine products Farhat Nasim10 Jun 2019 9:00 AM ISTThe forum will examine the rapidly developing science in relation to nicotine and its use, including policy and regulatory responses.New Delhi: Amid a...
Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China Farhat Nasim3 Jun 2019 11:00 AM ISTDr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care Medical Dialogues Bureau3 Jun 2019 9:45 AM ISTThe new version of NAVIFY Tumor Board is initially available in the United States and Canada with additional markets to follow in the near future.New...
Novartis wins USFDA approval for first PI3K inhibitor for breast cancer Farhat Nasim27 May 2019 6:10 PM ISTThe drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
GSK reintroduce incentives for sales representatives Farhat Nasim24 May 2019 9:31 AM ISTGSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups Meghna A Singhania22 May 2019 5:25 PM ISTNew Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
